The National Comprehensive Cancer Network’s Oncology Research Program’s grant will advance scientific knowledge of hematologic toxicity of PARPi in the treatment of patients with prostate cancer. PLYMOUTH MEETING, Pa., Dec. 11, 2024 /PRNewswire/ — The National Comprehensive Cancer…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.